Early-onset Alzheimer's shows distinct warning signs, not traditional heart risk factors

A Finnish research team has identified a puzzle that upends what doctors thought they knew about Alzheimer's disease in younger people. When the disease strikes before age 65, it does not announce itself through the usual suspects—high blood pressure, high cholesterol—that typically precede Alzheimer's in older patients. Instead, it arrives quietly, trailing a different set of warnings: depression, hearing loss, dizziness, headaches, and a cascade of neurological disturbances that accumulate in the years leading up to diagnosis.

The study, conducted by researchers at the University of Oulu and the University of Eastern Finland, examined 407 people diagnosed with early-onset Alzheimer's disease and compared their medical histories over 15 years with those of more than 4,000 age- and sex-matched controls without neurodegenerative disease. What emerged was a distinct health profile that separates early-onset Alzheimer's from its late-onset counterpart. In the five years before diagnosis, people who would develop early-onset Alzheimer's were significantly more likely to experience depression, dizziness, headaches, traumatic brain injuries, epilepsy, cerebrovascular disorders, thyroid diseases, and problems tied to heavy alcohol use. Hearing loss and tinnitus appeared even earlier, already elevated six to ten years before diagnosis.

The absence of traditional cardiovascular risk factors was striking. High blood pressure and hyperlipidemia—conditions that loom large in late-onset Alzheimer's—were no more common in the early-onset group than in the control population. This finding suggests that the biological mechanisms driving Alzheimer's in working-age adults may differ fundamentally from those in older patients. The researchers found no significant differences in overall disease burden when they looked back 11 to 15 years before diagnosis, indicating that the identifiable changes cluster closer to disease onset itself.

Adjunct Professor Johanna Krüger, the study's lead investigator, framed the implications plainly: early-onset Alzheimer's is not simply a younger version of the disease that strikes later in life. The familiar cardiovascular risk factors give way to a different constellation of health problems. This distinction matters because it changes where clinicians should direct their attention when evaluating working-age patients with cognitive concerns.

Another critical finding emerged from tracking healthcare utilization patterns. In the five years preceding diagnosis, people with early-onset Alzheimer's made increasingly frequent visits to healthcare providers. The surge accelerated sharply in the final year before diagnosis. This pattern suggests that patients accumulate a growing burden of seemingly unrelated symptoms and medical encounters—a recognizable trajectory that, if identified, could prompt earlier suspicion of neurodegenerative disease.

Laura Leppänen, the study's first author and a doctoral researcher at the University of Oulu, emphasized that no single symptom or condition predicts Alzheimer's disease. But the overall pattern—the accumulation of depression, neurological symptoms, hearing problems, and rising healthcare contacts—could serve as a signal. Currently, diagnosis of early-onset Alzheimer's remains challenging, and several years often pass between the appearance of first symptoms and formal diagnosis. Recognizing this pattern earlier could narrow that gap.

The research was grounded in patient data from memory clinics at Oulu University Hospital and Kuopio University Hospital, supplemented by nationwide health register data. The findings point toward a practical shift in how clinicians approach working-age adults presenting with cognitive decline or multiple unexplained health problems. Rather than waiting for the cardiovascular markers that signal late-onset disease, physicians might look for the neurological and psychiatric warning signs that characterize the early-onset form. For patients in their 40s and 50s, this distinction could mean the difference between years of diagnostic uncertainty and earlier intervention.